Drugs / [11C]BMT-136088
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02017730 | Jan 2014 → Jan 2015 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]BMT-136088 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02017730 ↗ |
| Modality | Diagnostic / imaging agent | “novel positron emission tomography (PET) tracer \[11C\]BMT-136088” NCT02017730 ↗ |
| Route | Intravenous | “Intravenous (IV) bolus plus infusion of \[11C\]BMT-136088” NCT02017730 ↗ |